Intervention Review

Antiglucocorticoid treatments for mood disorders

  1. Peter Gallagher2,
  2. Navdeep Malik3,
  3. James Newham3,
  4. Allan H Young4,
  5. I Nicol Ferrier1,
  6. Paul Mackin1,*

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 10 SEP 2007

DOI: 10.1002/14651858.CD005168.pub2

How to Cite

Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P. Antiglucocorticoid treatments for mood disorders. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD005168. DOI: 10.1002/14651858.CD005168.pub2.

Author Information

  1. 1

    University of Newcastle upon Tyne, Department of Psychiatry, Newcastle upon Tyne, UK

  2. 2

    University of Newcastle upon Tyne, School of Neurology, Neurobiology and Psychiatry, Newcastle upon Tyne, UK

  3. 3

    Leazes Wing, The Royal Victoria Infirmary, Department of Psychiatry, Newcastle upon Tyne, UK

  4. 4

    University of British Columbia, Department of Psychiatry, Vancouver, Canada

*Paul Mackin, Department of Psychiatry, University of Newcastle upon Tyne, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008


Cited in:


This article has been cited by:

  1. 1
    Alix Warburton, Abigail L. Savage, Paul Myers, David Peeney, Vivien J. Bubb, John P. Quinn, Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF, Journal of Affective Disorders, 2015, 172, 63


  2. 2
    Dennis J.L.G. Schutter, Jack van Honk, An endocrine perspective on the role of steroid hormones in the antidepressant treatment efficacy of transcranial magnetic stimulation, Psychoneuroendocrinology, 2010, 35, 1, 171


  3. You have free access to this content3
    Owen M. Wolkowitz, Elissa S. Epel, Victor I. Reus, Synthia H. Mellon, Depression gets old fast: do stress and depression accelerate cell aging?, Depression and Anxiety, 2010, 27, 4
  4. 4
    Uma Rao, Li-Ann Chen, Anup S. Bidesi, Mujeeb U. Shad, M. Albert Thomas, Constance L. Hammen, Hippocampal Changes Associated with Early-Life Adversity and Vulnerability to Depression, Biological Psychiatry, 2010, 67, 4, 357


  5. 5
    Uma Rao, Constance L. Hammen, Russell E. Poland, Longitudinal Course of Adolescent Depression: Neuroendocrine and Psychosocial Predictors, Journal of the American Academy of Child & Adolescent Psychiatry, 2010, 49, 2, 141


  6. 6
    G. S. Malhi, D. Adams, L. Lampe, M. Paton, N. O’Connor, L. A. Newton, G. Walter, A. Taylor, R. Porter, R. T. Mulder, M. Berk, Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, 2009, 119,
  7. 7
    Stuart Watson, Paul Mackin, HPA axis function in mood disorders, Psychiatry, 2009, 8, 3, 97


  8. You have free access to this content8
    Gin S Malhi, Danielle Adams, Michael Berk, Medicating mood with maintenance in mind: bipolar depression pharmacotherapy, Bipolar Disorders, 2009, 11,
  9. 9
    Kalypso Markopoulou, Andrew Papadopoulos, Mario F. Juruena, Lucia Poon, Carmine M. Pariante, Anthony J. Cleare, The ratio of cortisol/DHEA in treatment resistant depression, Psychoneuroendocrinology, 2009, 34, 1, 19


  10. 10
    Rodrigo Machado-Vieira, Ioline Henter, Jacqueline Baumann, David Latov, Cristina Wheeler-Castillo, Carlos A. Zarate, Novel Therapeutic Approaches for Treating Bipolar Disorder,